The $290 bln UK-based company will licence weight-loss drugs from China’s CSPC in a deal worth up to $18.5 bln. It’s the latest overseas giant drawn to the Asian country’s growing biotech prowess. But ...

CSPC Pharmaceutical Group and AstraZeneca have entered a global collaboration and licensing deal to co develop long acting ...

A customs duty exemption on select high-cost cancer and rare disease therapies is expected to lower treatment costs for ...

GSK needs drugs in the pipeline to offset some significant patent expiries in the next few years, in particular branded versions of its HIV medicine dolutegravir, which lose US and European ...

The move can significantly lower out‑of‑pocket burdens for families, given that India’s health insurance coverage for ...

Experts criticize Union Budget 2026 for minimal healthcare allocation, lacking significant relief from out-of-pocket expenses and medical inflation.

Budget 2026 exempts drugs for cancer and rare diseases from customs duties, but concerns persist about actual patient ...

Get all latest & breaking news on Premier Energies. Watch videos, top stories and articles on Premier Energies at moneycontrol.com.

The UK pharmaceutical giant has announced a landmark $15bn China investment during the UK prime minister’s visit, marking its largest expansion yet to boost manufacturing, R&D and biotech ...

ONC, extended its collaboration with InSysBio to apply mechanistic translational modeling to clinical trial design. The expanded partnership focuses on refining dosing regimens and addressing safety ...

Stock market today: According to Ponmudi R, CEO of Enrich Money, markets are likely to remain highly volatile, with sharp moves possible in either direction depending on key announcements around ...

MZUZU-(MaraviPost)-The Castel Challenge Cup quarter finals match between Mzuzu City Hammers and Mighty Wanderers ended in a nail-biting 5-3 penalty shootout win for Hammers after the game ended 1-1 at ...